Vimarsana
Biggest News Aggregation in the World

Page 30 - Open Orphan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Open Orphan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Open Orphan Today - Breaking & Trending Today

Open Orphan due diligence completed by Liberum Capital - DirectorsTalk Interviews - Vimarsana News

Open Orphan due diligence completed by Liberum Capital - DirectorsTalk Interviews

Open Orphan due diligence completed by Liberum Capital

Poolbeg Pharma PLC Announces US Patents Granted for POLB 001 and POLB 002 - Vimarsana News

Poolbeg Pharma PLC Announces US Patents Granted for POLB 001 and POLB 002

Further Expansion of IP Portfolio Enhancing Protection of Poolbeg's Growing PipelineLONDON, UK / ACCESSWIRE / May 26, 2022 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a clinical

Open Orphan to publish full year results on 7 June 2022 - DirectorsTalk Interviews - Vimarsana News

Open Orphan to publish full year results on 7 June 2022 - DirectorsTalk Interviews

Open Orphan to publish full year results on 7 June 2022

Open Orphan PLC on its subsidiary's new study contract - Vimarsana News

Open Orphan PLC on its subsidiary's new study contract

Yamin Khan, chief executive at Open Orphan, joined Katie to talk about Hvivo, a subsidiary of Open Orphan, signing a multi-million pound influenza human...

Related Topics:
Yamin KhanOpen Orphan
Open Orphan's hVIVO wins a £7.3m influenza human challenge study - Vimarsana News

Open Orphan's hVIVO wins a £7.3m influenza human challenge study

Open Orphan's hVIVO wins a £7.3m influenza human challenge study